Novo Nordisk A/S (ADR) - NVO - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: May 12, 2013

Novo Nordisk A/S (ADR) - SIC # 2834

Ticker	Exchange	SIC #	Website	Latest Ticker
NVO	New York	2834	http://www.novonordisk.com	171.99 0.00
Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company: Publicly Traded Company Industry Ratios Publicly Traded Company VS. Industry Ratios Publicly Traded Company VS Publicly Traded Company Private Company VS Publicly Traded Company
Latest Headlines for Novo Nordisk A/S (ADR) Why MannKind's Afrezza Will Succeed Where Pfizer Failed - May 18th, 2013 2:45 am Good News For Health Care Stocks - May 17th, 2013 9:50 am InPlay: Novo Nordisk A/S reports positive results from first phase 3 trial with long-acting factor IX for treatment of haemophilia B - May 17th, 2013 6:39 am Finny Kuruvilla, Portfolio Manager of the Eventide Gilead Fund, Interviews with The Wall Street Transcript: Investing in Health Care Innovation - May 16th, 2013 11:23 am Will Obesity Drugs Gain Soon? - May 15th, 2013 6:42 am What Does This Failure Mean for Eli Lilly Investors? - May 14th, 2013 4:30 pm Does the Healthcare Industry mean Stability? - May 14th, 2013 4:00 pm Novo Nordisk Rapidly Raising Dividend - May 14th, 2013 3:49 pm Why This Stock's Crash is a Buying Opportunity - May 14th, 2013 2:25 pm The Ups and Downs of Diabetes - May 8th, 2013 11:38 am 3 Stocks Improving Performance Of The Health Care Sector - May 6th, 2013 11:03 am Sixty-One Per Cent of Women Say their Sex Lives are Suffering Due to a Condition of Menopause - May 6th, 2013 3:59 am Why Investors Shouldn't Worry About Sanofi's Poor Quarter - May 3rd, 2013 5:31 pm Novo Nordisk A/S køber B-aktier til en værdi af 2,5 mia. kr. fra Novo A/S som led i det løbende aktietilbagekøbsprogram - May 3rd, 2013 1:55 pm Novo Nordisk A/S purchases B shares worth DKK 2.5 billion from Novo A/S as part of the on-going share repurchase programme - May 3rd, 2013 1:55 pm Trading in Novo Nordisk shares by board members, executives and associated persons on 1 May 2013 - May 2nd, 2013 12:55 pm One Soda a Day Keeps Your Health Away - May 2nd, 2013 11:36 am Novo Nordisk A/S Management Discusses Q1 2013 Results - Earnings Call Transcript - May 2nd, 2013 11:20 am David Amsellem, Managing Director and Senior Research Analyst at Piper Jaffray & Co., Interviews with The Wall Street Transcript: Alternative Dosage Forms Create Barriers Against Competition in Generics - May 2nd, 2013 9:08 am Earnings and Sales Rise at Novo Nordisk - May 2nd, 2013 6:25 am View All Current Headlines >>